- Sections
- C - Chimiemétallurgie
- C07K - Peptides
- C07K 14/565 - IFN-bêta
Détention brevets de la classe C07K 14/565
Brevets de cette classe: 246
Historique des publications depuis 10 ans
|
26
|
27
|
15
|
13
|
24
|
18
|
19
|
18
|
21
|
11
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| The Regents of the University of California | 19989 |
12 |
| Orionis Biosciences BV | 83 |
11 |
| Abion Inc. | 67 |
10 |
| Modernatx, Inc. | 1259 |
10 |
| Orionis Biosciences Inc. | 95 |
10 |
| Biogen MA Inc. | 895 |
8 |
| East Carolina University | 183 |
7 |
| Ubiprotein, Corp. | 12 |
7 |
| Mayo Foundation for Medical Education and Research | 3225 |
6 |
| Faron Pharmaceuticals Oy | 88 |
6 |
| Glytech, Inc. | 65 |
6 |
| Universiteit Gent | 1336 |
6 |
| Vib VZW | 880 |
6 |
| Ares Trading S.A. | 294 |
5 |
| CytomX Therapeutics, Inc. | 222 |
5 |
| Rutgers, The State University of New Jersey | 1896 |
5 |
| Idemitsu Kosan Co., Ltd. | 4227 |
4 |
| The Brigham and Women's Hospital, Inc. | 2197 |
4 |
| Immunwork Inc. | 26 |
4 |
| Synairgen Research Limited | 9 |
4 |
| Autres propriétaires | 110 |